|
2024
|
G/S
|
Printed publications, namely, brochures, newsletters, and pamphlets relating to medical issues, p... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders.. Providing health inform... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders. Providing healthcare pro... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
neurological disorders. Providing healthcare pr... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders. Providing medical inform... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
neurological disorders. Providing medical infor... |
|
|
G/S
|
Pharmaceutical preparations. Providing health information to patients and healthcare
professiona... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders, namely, epilepsy, seizur... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders Providing healthcare prov... |
|
|
G/S
|
Pharmaceutical preparations Providing health information to patients and healthcare professionals... |
|
|
Invention
|
Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opene... |
|
|
Invention
|
Methods and uses for treating anhedonia. The present disclosure is directed to, among other thing... |
|
|
Invention
|
Conjoint therapy for treating seizure disorders.
In certain embodiments, the present disclosure ... |
|
|
Invention
|
Methods for treating pain.
In certain embodiments, the present disclosure is directed to methods... |
|
2023
|
Invention
|
Solid state crystalline forms of a selective potassium channel modulator.
The present disclosure... |
|
|
Invention
|
Pyridinamine derivatives and their use as potassium channel modulators.
The present disclosure i... |
|
|
Invention
|
Pyridinamine derivatives and their use as potassium channel modulators. The present disclosure is... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
neurological disorders. Providing health inform... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders. Providing health informa... |
|
2022
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders Providing health informat... |
|
|
Invention
|
Pyridinylacetamide derivatives as sodium channel activators.
The present disclosure is directed ... |
|
|
Invention
|
Pyridinyl derivatives as sodium channel activators.
The present disclosure is directed to compou... |
|
|
Invention
|
Pyridine derivatives and their use as sodium channel activators. The present disclosure is direct... |
|
|
Invention
|
Pyridinylacetamide derivatives as sodium channel activators. The present disclosure is directed t... |
|
|
Invention
|
Pyridinyl derivatives as sodium channel activators. The present disclosure is directed to compoun... |
|
|
Invention
|
Conjoint therapy for treating seizure disorders. In certain embodiments, the present disclosure i... |
|
|
Invention
|
Voltage-gated potassium channel opener for use in treating anhedonia. The present disclosure is d... |
|
|
Invention
|
Conjoint therapy for treating seizure disorders. NHH-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-di... |
|
2021
|
Invention
|
Methods for treating absence seizures.
In certain embodiments, the present disclosure is directe... |
|
|
Invention
|
Flunarizine for use in treating absence seizures. The present disclosure is directed to flunarizi... |
|
|
Invention
|
Therapeutic compounds and methods of use thereof.
The invention provides a method of treating a ... |
|
|
Invention
|
Solid state forms of a selective potassium channel modulator.
The present disclosure provides so... |
|
|
Invention
|
Use of the nav1.6 sodium channel blocker (s)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-... |
|
|
Invention
|
Pharmaceutical formulations for treating diseases associated with voltage-gated sodium channels. ... |
|
|
Invention
|
Use of the navi.6 sodium channel blocker (s)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-... |
|
|
Invention
|
Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents. This invention ... |
|
|
Invention
|
Substituted benzamides and methods of use thereof.
The invention provides compounds having the g... |
|
2020
|
Invention
|
Methods of treating pain.
In certain embodiments, the present disclosure is directed to methods ... |
|
|
Invention
|
Use of a kv7 potassium channel opener for treating pain. In certain embodiments, the present disc... |
|
|
Invention
|
Use of a kv7 potassium channel opener for treating pain. NHH-isoquinolin-2-yl)-2,6-dimethylphenyl... |
|
|
Invention
|
Pediatric immediate-release formulation of the potassium channel opener ezogabine. Disclosed here... |
|
|
Invention
|
Pediatric immediate-release formulation of the potassium channel opener ezogabine.
Disclosed her... |
|
|
Invention
|
Methods of treating depressive disorders. In certain embodiments, the present disclosure is direc... |
|
|
Invention
|
Methods of treating depressive disorders. NHH-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylb... |
|
|
Invention
|
Solid state crystalline forms of a selective potassium channel modulator. The present disclosure ... |
|
|
Invention
|
Therapeutic compounds and methods of use thereof.
The invention provides a compound of formula:
... |
|
|
Invention
|
Substituted benzamides and methods of use thereof. The invention provides compounds having the ge... |
|
|
Invention
|
Benzenesulfonamide compouds and their use as therapeutic agents. This invention is directed to be... |
|
2015
|
G/S
|
Development of data base systems for genetic and clinical analyses of human diseases; research an... |
|
2000
|
G/S
|
RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGY |
|
|
G/S
|
RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGY, NAMELY, DEVELOPING DIAGNOSTIC AND THERAPEUTIC AGENTS F... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; diagnostic and therapeutic agents. Biotechn... |
|
|
G/S
|
BIOTECHNOLOGY RESEARCH AND DEVELOPMENT; [ DEVELOPMENT OF DATA BASE SYSTEMS FOR GENETIC AND CLINIC... |
|
|
G/S
|
Biotechnology research and development, namely, developing diagnostic and therapeutic agents for ... |
